In vitro modelling of bone infection for osteomyelitis and osteoradionecrosis

Nc3Rs · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

August 31, 2028
Response Due
Active
Status

Opportunity Overview

Bone infections, including osteomyelitis and osteoradionecrosis, cause significant morbidity and mortality, especially in elderly people where osteomyelitis is the second most critical musculoskeletal infection.[1] These conditions can have devastating consequences, including severe pain, bone destruction, amputation, and even sepsis and death. Current treatments often have limited success, and the development of more effective therapies requires a better understanding of the underlying mechanisms of disease development/aetiology. There is a critical need for models that accurately replicate the pathophysiology of bone infections.

The use of animal models for studying bone infections has provided valuable insights into the pathophysiology of these diseases.[2] However, animal models have several limitations, including ethical concerns, high cost, and poor reproducibility. In vitro models that accurately replicate the pathophysiology of these infections could offer an alternative to animal testing, allowing researchers to explore the complex interactions between microbial pathogens, immune endothelial cells, and bone-resident osteoblasts/osteocytes in a more controlled and reproducible manner.

In vitro models could facilitate the exploration of complex interactions between microbial pathogens, endothelial cells, and bone-resident cells, leading to a better understanding of these diseases and the development of more effective treatments. Despite the recent advances tissue engineered organotypic in vitro models of bone,[3,4] there are still a critical lack of models mimicking the pathophysiology[5] of infected bone, such as osteomyelitis or infection, associated with the development of necrotic tissue due to radiation - collectively known as osteoradionecrosis.

Here, we propose develop advanced in vitro models of osteomyelitis and osteoradionecrosis, with the ultimate goal of replacing animal models that cause severe harm. We will advance 3D iPSCs-based cell...

This is one of 1,833 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyNc3Rs
CountryUnited Kingdom
CategoryResearch Development
PublishedNovember 01, 2025
Procurement stageActive solicitation
Response dueAugust 31, 2028
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Organ-on-a-chip modelling of respiratory-vascular cell-cell communication in Chronic Obstructive Pulmonary Disease (COPD)
Novel, biologically relevant, in vitro model of the blood-brain tumour barrier (BBTB)
RFI - Child Digital Health Services
Capital Programme Delivery Framework(s)
Pharmaceutical Wholesale Services
715863477 - Defence Hard Facilities Management (UK Estate)
Integrated Partnerships Framework
Southern Construction Framework (SCF-6)

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.